echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medicines Company News > Ten years of grinding a sword Li Zhu will take the first imitation of this heavy injection.

    Ten years of grinding a sword Li Zhu will take the first imitation of this heavy injection.

    • Last Update: 2020-10-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Medicine Network October 13 Source: The State Drug Administration's official website Danqulin sodium is a synactical muscle relaxant that can reduce skeletal muscle contractions and is clinically used to treat and prevent malignant hyperthermal fever.
    malignant hyperthermal fever, also known as anaesthetic fever, is a genetic myopathy characterized by high metabolism, which is a rare disease.
    is currently listed in the United States, the European Union, Japan and other countries and regions, mostly capsules and injections.
    only 2 enterprises in China hold the Danqulin sodium capsule production approval, no injection of Danqulin sodium was approved for listing, Lizhu's products are expected to fill the gap in the market.
    : Lizhu Group injection with Danqulin sodium declaration Source: Mi net one-click retrieval Lizhu Group in 2009 project development of injection of danqulin sodium, 2015 with new drug class 3.3 declared clinical, February 2017 with "rare Illness" was included in the priority review, approved clinical in December of the same year, in February 2019, the company to copy 3 categories of exclusive production and CDE contractor acceptance, in April of the same year on the grounds of "rare diseases" into the priority review, in October 2020 into the administrative approval stage. Table
    : 2020 to date Lizhu Group's new classification products source: Minet MED2.0 China Drug Review Database Minet data show that 2020 so far Lizhu Group has 4 varieties to copy 4 categories of declared listing, 3 for injections, including long-chain fat milk injection (OO), injection acetate octreotide micro-ball has not been approved for generic drugs listed.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.